Latest Research in Cancer Immunotherapy and Biomarkers
174 research papers · 0.0 average citations · 2026 median publication year
Top Research Topics in Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers — 20 papers
- Cancer Genomics and Diagnostics — 19 papers
- Renal cell carcinoma treatment — 12 papers
- Single-cell and spatial transcriptomics — 9 papers
- Ferroptosis and cancer prognosis — 8 papers
- Extracellular vesicles in disease — 5 papers
- Pancreatic and Hepatic Oncology Research — 5 papers
- Immune cells in cancer — 5 papers
- Barrier Structure and Function Studies — 5 papers
- Epigenetics and DNA Methylation — 4 papers
Highest-Cited Papers
- Extensive and differential platinum chemotherapy mutagenesis in livers of children (1 citations)
- Successful Engraftment Following Second Cord Blood Transplantation After Graft Failure in a Child With Relapsed B-ALL.
- Integrated multi-omics analysis of cfDNA and protein biomarkers for multi-cancer early detection from a single blood draw
- Metabolic Alterations in Blood and Saliva During the First Two Cycles of Adjuvant Chemotherapy Correlate with 5-FU Dose Reduction Requirement in Patients with Colorectal Cancer
- Genomic and transcriptomic landscape of spread through air spaces in stage 1 lung adenocarcinoma
- Bridging the gap: a genetically validated avian chorioallantoic membrane platform for investigation of spontaneous circulating tumor cells
- Compartment-specific CD8 infiltration and disease-specific survival in resected ampullary adenocarcinoma
- Exploration of the immunogenomics connection between chronic obstructive pulmonary disease and lung cancer: The role of liquid biopsy in early diagnosis and precision prognosis
- Integrative single-cell and spatial transcriptomic analyses identify LMX1B as a tumor suppressor orchestrating the GDF15–ATP4B axis in renal cell carcinoma
- Allele-specific directionality and evolutionary timing of BRCA1/2 loss of heterozygosity in gastric cancer
- Eomesodermin in renal cell carcinoma: Epigenetic and immune crosstalk driving tumor progression (Review)
- Claudin 18.2 Expression and Outcomes in Resected Gallbladder and Biliary Tract Adenocarcinomas: A Pilot Clinicopathologic Study
- Precision medicine in cancer: A comprehensive review of advanced cancer diagnosis technologies and personalized treatment strategies
- Association of TNF-α, TGF-β1, IFN-γ, IL-6, and IL-10 Gene Polymorphisms with Hodgkin Lymphoma: Susceptibility and Clinical Outcomes
- Pre-existing immunity and hrHPV status determine immunotherapy response in advanced penile cancer: biomarkers and overall survival in the PERICLES trial
- Combination Immunotherapy in Pancreatic Cancer: Current Clinical Evidence and Mechanistic Rationale for Overcoming a “Cold” Tumor
- Exploring a DNA methylation field effect in renal cell carcinoma and its implications for biomarker research
- G2/M Checkpoint Dependency in High-Grade Serous Tubo-Ovarian Carcinoma: Mechanisms and Therapeutic Implications
- Targeted Cepharanthine-Mediated Dual-Pathway Inhibition Sensitizes Pancreatic Cancer to Gemcitabine
- Role of BTLA in ovarian cancer and its clinical prognostic significance based on multi-omics analysis